Back to CVE records
Medium 5.4Published Oct 3, 2025
CVE-2025-52653HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application.
Updated under an hour ago ()
Does this affect you?
It affects hcltech dryice_myxalytics. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Start free and add your stack
Free account, 1 product
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
- CVSS
- 5.4 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Oct 8, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
hcltech dryice_myxalytics hcltech:dryice_myxalytics | 6.6 | NVD |
References
- https://support.hcl-software.com/csm?id=kb_article&sysparm_article=KB0124411vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.